Thank you for a great factual post Chris.
We all tend to anchor our expectations to something (it’s an unfortunate human nature bias), but in the absence of any other info I think the info that comes from the horses mouth is the best place to start!
If WP says less than the competition (<$30k) why are we pricing in TAVR at $45K?
Each to their own I guess, but I’m no med-tech expert so I’ll take our CEOs word for it until more info proves / disproves his assumption.
TAVR gains interest at JPM, page-46
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.35 | 88 | 1 |
View Market Depth
| Last trade - 07.02am 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable